SELENOP and neuroblastoma: Immunohistochemistry staining showed that the level of SEPP1, FGL2, KLRK1, and ABCA6 were lower in the high risk NB samples, while the expression of GAL was higher in the high risk NB samples(p < 0.05, Figure 7).